The Test That Doesn't Tell You Enough: Drug Testing in Residential Care and What Good Practice Actually Requires

Drug testing in children's residential care — the routine or periodic collection of urine or saliva samples from young people to detect the presence of illicit substances — has become widespread in the sector in a way that is rarely examined with the scrutiny it deserves. Many homes have established testing protocols that operate as a matter of course: on admission, after missing episodes, following changes in behaviour, on a periodic basis, or on suspicion. The practice is presented in most homes as a safeguarding measure — a way of knowing what a young person is using and when, of maintaining oversight of their risk, of demonstrating to placing authorities and inspectors that the home is actively monitoring and responding to substance use. These rationales are not entirely without substance, but they are also not as self-evidently sound as they tend to be presented. Drug testing is an intervention with real consequences for young people, for the therapeutic relationship between staff and young people, and for the credibility of homes as places that genuinely understand why young people use substances and what actually helps them. The question of whether, when, and how to test is not a compliance question. It is a care quality question, and it deserves to be treated as one.

The legal position on drug testing in residential care is less straightforward than many homes assume. A urine or saliva drug test constitutes a search and physical examination of a person's body, and under Article 8 of the European Convention on Human Rights — incorporated into domestic law through the Human Rights Act 1998 — every person has a right to respect for their private life, including their bodily integrity. This right is not absolute; it can be interfered with where the interference is lawful, necessary, and proportionate. But it must be interfered with on those grounds, which requires a legal basis, a legitimate aim, and a proportionate application in each individual case. In the context of children's residential care, the picture is complicated further by the question of who holds parental responsibility and what they can consent to on a child's behalf. Parental responsibility for looked-after children is typically shared across birth parents, the local authority, and in some configurations the registered provider — but the precise arrangement varies, and none of it extinguishes the child's own developing right to autonomy, particularly for young people in mid-to-late adolescence. A sixteen-year-old in residential care who has capacity to consent to or refuse medical treatment has a meaningful say in whether they submit to a drug test. A home that tests young people routinely, without individual decision-making about necessity and proportionality, without meaningful engagement of the young person in that decision, and without a clear and documented legal basis for the interference, is on more uncertain ground than most testing policies reflect. Ofsted has noted with concern, in inspections of residential homes, instances of drug testing that appeared to be routine, punitive, or untethered from any clear analysis of why it was needed for a particular young person at a particular time. This is not a marginal concern.

Leaving the legal and rights questions aside, there is a more fundamental problem with drug testing as a safeguarding tool: its informational value is significantly lower than most people using it assume. A positive test for cannabis, for example, tells you that the person tested has used cannabis at some point within the preceding days or weeks — the detection window for THC in urine can extend to thirty days or more for frequent users. It does not tell you how recently they used, how much they used, in what circumstances they used, whether they were coerced or made a free choice, whether their use is escalating or decreasing, or what function that use is serving in the context of their current life and mental state. It does not tell you whether they want help, whether they know what help looks like, or whether the relationship with the home is one in which they would feel safe enough to disclose and ask. All of the information that actually drives good practice in response to a young person's substance use is absent from a positive test result. What a positive test gives a home is a data point that confirms something it probably already suspected, that the young person knows the home now has, and that the young person will experience as confirmation that the home was checking up on them — not talking to them, not trying to understand them, but monitoring them. The information generated by a test needs to be weighed against the relationship cost of generating it. In most cases, that calculation has not been done. In many cases, it has not been attempted.

The most powerful argument against routine drug testing in residential care is not legal; it is relational. Young people who use substances in the care system are, with great consistency, using them as a means of managing experiences that are not being adequately addressed by the formal support around them: trauma histories, mental health difficulties, boredom, grief, peer influence, the specific vulnerabilities that contextual safeguarding frameworks have made visible. Understanding and addressing those underlying drivers is the work that actually reduces harmful substance use over time. A home that understands its role primarily as detection and sanction — however this is wrapped in supportive language — is not positioned to do that work. A young person who knows they will be tested following a missing episode will adjust their behaviour accordingly: they will use less traceable substances, they will use in ways that fall outside detection windows, they will be less likely to return to the home promptly because they know what is waiting when they do. The testing does not reduce the use; it changes its pattern in ways that may make it less visible and more dangerous. More fundamentally, a young person who is asked to provide a urine sample to be analysed for substances has been placed in a relational dynamic with the home that is not compatible with the therapeutic work of helping them understand and address their substance use. Trust is the necessary precondition for disclosure, for honest conversation about what a young person is taking and why, for the kind of motivational engagement that might begin to shift their relationship with substances. Testing does not build trust. In most cases, it erodes it, and the erosion is cumulative: the young person who has been tested repeatedly without meaningful dialogue about why is a young person who has learned that the home's response to their substance use is surveillance, not understanding.

None of this is an argument that drug testing is never appropriate in a residential home for children. There are circumstances in which testing can serve a legitimate purpose: where a young person has themselves requested testing as part of their own strategy for managing use, where there is specific clinical concern about the interaction between a substance and a prescribed medication, or where a safeguarding concern about criminal exploitation has reached a point at which evidence of what a young person is being given carries real protective weight. In these circumstances, the decision to test should be made individually, based on a clear documented analysis of the purpose and proportionality, with the young person's informed understanding, and with a clear plan for what happens with the result — including what support will be offered regardless of the outcome. What should not exist is a blanket testing protocol that applies to all young people on arrival, or to all situations of a particular type. The Children's Homes (England) Regulations 2015 and the accompanying Quality Standards do not require drug testing, and homes should be cautious about practices that have become normalised in the sector without ever being properly scrutinised. A home that genuinely understands substance use — its functions, its patterns, its relationship to trauma and unmet need — does not need a test to know that a young person is using. It knows, through the quality of its relationships, through its daily observation, through the conversations it has created the conditions for. That knowledge is richer, more actionable, and more consistent with the therapeutic intent of residential care than anything a testing kit can produce. The question for any home should not be "how do we detect substance use?" but "how have we built the relationships and created the conditions in which a young person might tell us?" That is harder to answer. It is also, for the young people concerned, the question that actually matters.